AQW 19095/17-22 Written question to the Minister of Health
To ask the Minister of Health to detail the number of patients that could benefit from Tagrisso (Osimertinib) as a post-surgery treatment for early-stage lung cancer.
Asked by Stewart Dickson MLA on 19 May 2021
- Answered
- Written
- After due date
- Tabled
- 19 May 2021
- Answer due by
- 4 June 2021
- Answered
- 10 June 202122 days after tabling
- Department
- Department of Health
- Priority question
- No
Answer
Precise figures on the number of patients that could benefit from Tagrisso (osimertinib) as a post-surgery treatment for early-stage lung cancer are not available.
I wish to offer the assurance that patients in Northern Ireland will have the same access to Tagrisso as patients in the rest of the United Kingdom, within the National Institute for Health and Clinical Excellence (NICE) guidelines.